FDA Approves Teal Wand as First At-Home Cervical Cancer Screening
Teal Health, the company manufacturing and distributing the test, says thousands of women are already on a waiting list for the assay
Emerging Tests-dtet
Rethinking Lyme Disease Testing: A New Approach to Early Detection
New research marks a promising step toward rethinking how we identify and manage Lyme disease and related infections in the clinical lab
Diagnostics Pipeline: FDA Approves Visby Medical’s Over-The-Counter Women’s Sexual Health Test
It’s the first PCR-based sexually transmitted infection test platform for at-home use
Already a member? Log in here
Genetic Testing: Multigene Panel Testing Detects Hereditary Risk Variants in Metastatic Breast Cancer Patients
From - Diagnostic Testing & Emerging Technologies
The clinical value of performing multigene panel for inherited cancer in patients with metastatic breast cancer has…
Top of the News: Early Results Show Blood Test’s Effectiveness in Early Alzheimer’s Detection
From - Diagnostic Testing & Emerging Technologies
Developing a cost-effective blood test capable of accurately detecting early Alzheimer's disease that can be…
Nonculture Molecular Tests Speed Diagnosis of Bloodstream Infections
From - Diagnostic Testing & Emerging Technologies
The T2Bacteria Panel (T2Biosystems; Lexington, Mass.) can rapidly and accurately diagnoses bloodstream infections (BSIs) caused by…
Researchers Find Marker That May Aid Diagnosis of Erectile Dysfunction
From - Diagnostic Testing & Emerging Technologies
The neutrophil-lymphocyte ratio (NLR) may be a marker to aid in diagnosing erectile dysfunction (ED), according to…
HPV DNA from Oral Rinse Samples May Be Prognostic Marker for Head, Neck Cancer
From - Diagnostic Testing & Emerging Technologies
Samples collected from a mouth rinse can detect human papillomavirus (HPV) DNA. These easily collected samples might provide important monitoring information for…
Improved Accuracy of Point-of-Care HbA1c Tests May Expand Access to Testing
From - Diagnostic Testing & Emerging Technologies
The U.S. Food and Drug Administration-cleared POC Afinion HbA1c Dx test (Alere Technologies a subsidiary of Abbott Laboratories) is accurate and…
Already a member? Log in here
New Point-of Care Paper Test May Improve Diagnosis of Preeclampsia
From - Diagnostic Testing & Emerging Technologies
The Congo Red Dot (CRD) Paper Test is a simple, rapid, non-invasive tool that that may improve triage and the accuracy of preeclampsia (PE) diagnosis at the point of care, according to…
Progress Seen With EGFR Testing, But Adoption Still Lagging
From - Diagnostic Testing & Emerging Technologies
Incomplete implementation of EGFR testing guidelines remains a problem in the realm of non-small cell lung cancer (NSCLC), according to a study published in…